244 related articles for article (PubMed ID: 37889392)
1. Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside.
Dos Santos Valsecchi VA; Betoni FR; Ward LS; Cunha LL
Rev Endocr Metab Disord; 2024 Feb; 25(1):5-17. PubMed ID: 37889392
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.
Álvarez-Sierra D; Marín-Sánchez A; Ruiz-Blázquez P; de Jesús Gil C; Iglesias-Felip C; González Ó; Casteras A; Costa RF; Nuciforo P; Colobran R; Pujol-Borrell R
J Autoimmun; 2019 Sep; 103():102285. PubMed ID: 31182340
[TBL] [Abstract][Full Text] [Related]
3. Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Mukherjee S; Dey P; Gupta R; Radotra B; Sachdeva N; Sood A; Bhadada SK; Bhansali A
Front Endocrinol (Lausanne); 2022; 13():931647. PubMed ID: 36518249
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
5. From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer.
D'Andréa G; Lassalle S; Guevara N; Mograbi B; Hofman P
Theranostics; 2021; 11(3):1310-1325. PubMed ID: 33391536
[TBL] [Abstract][Full Text] [Related]
6. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 and PD-1 expression in thyroid follicular epithelial dysplasia: Hashimoto thyroiditis related atypia and potential papillary carcinoma precursor.
Pakkanen E; Kalfert D; Ahtiainen M; Ludvíková M; Kuopio T; Kholová I
APMIS; 2022 May; 130(5):276-283. PubMed ID: 35238073
[TBL] [Abstract][Full Text] [Related]
8. Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1.
Álvarez-Sierra D; Sánchez-Gaona N; Cruz Cobo M; Escriche A; Abad M; Gómez-Brey A; Bello I; Caubet E; González Ó; Zafón C; Iglesias C; Moreno P; Petit A; Fernández-Sanmartín MA; Martínez-Gallo M; Pujol-Borrell R
J Autoimmun; 2023 Apr; 136():103013. PubMed ID: 36857863
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression in papillary thyroid cancer with and without lymphocytic thyroiditis: a cross sectional study.
Fadia M; Fookeerah P; Ali S; Shadbolt B; Greenaway T; Perampalam S
Pathology; 2020 Apr; 52(3):318-322. PubMed ID: 32107082
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-fat diet on thyroid autoimmunity in the female rat.
Liao Z; Kong Y; Zeng L; Wan Q; Hu J; Cai Y
BMC Endocr Disord; 2022 Jul; 22(1):179. PubMed ID: 35840950
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Toxicity Following Immune Checkpoint Inhibitor Treatment in Advanced Cancer.
Muir CA; Menzies AM; Clifton-Bligh R; Tsang VHM
Thyroid; 2020 Oct; 30(10):1458-1469. PubMed ID: 32264785
[No Abstract] [Full Text] [Related]
12. [100 years of Hashimoto thyroiditis, still an intriguing disease].
Baretić M
Acta Med Croatica; 2011 Dec; 65(5):453-7. PubMed ID: 22994016
[TBL] [Abstract][Full Text] [Related]
13. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
14. Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond.
Ai L; Xu A; Xu J
Adv Exp Med Biol; 2020; 1248():33-59. PubMed ID: 32185706
[TBL] [Abstract][Full Text] [Related]
15. T cell checkpoint regulators in the heart.
Grabie N; Lichtman AH; Padera R
Cardiovasc Res; 2019 Apr; 115(5):869-877. PubMed ID: 30721928
[TBL] [Abstract][Full Text] [Related]
16. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity and Cancer-Two Sides of the Same Coin.
Sakowska J; Arcimowicz Ł; Jankowiak M; Papak I; Markiewicz A; Dziubek K; Kurkowiak M; Kote S; Kaźmierczak-Siedlecka K; Połom K; Marek-Trzonkowska N; Trzonkowski P
Front Immunol; 2022; 13():793234. PubMed ID: 35634292
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
Kotwal A; Kottschade L; Ryder M
Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
[No Abstract] [Full Text] [Related]
19. Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases.
Ibañez-Vega J; Vilchez C; Jimenez K; Guevara C; Burgos PI; Naves R
J Autoimmun; 2021 Sep; 123():102702. PubMed ID: 34311143
[TBL] [Abstract][Full Text] [Related]
20. IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis.
Lu ZW; Hu JQ; Liu WL; Wen D; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32348468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
